Yüklüyor......
Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure
Second-line therapy for corticosteroid-refractory or -dependent acute graft-versus-host disease remains ill-defined, due to limited efficacy of drugs and evolving clinical trial endpoints. Six-month freedom from treatment failure has been proposed as a novel clinical trial endpoint and is defined by...
Kaydedildi:
| Yayımlandı: | Haematologica |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ferrata Storti Foundation
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4222474/ https://ncbi.nlm.nih.gov/pubmed/25150260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.108217 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|